Forskning ved Københavns Universitet - Københavns Universitet


Melanin concentrating hormone receptor 1 (MCHR1) antagonists - Still a viable approach for obesity treatment?

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningfagfællebedømt

Obesity is a global epidemic associated with multiple severe diseases. Several pharmacotherapies have been investigated including the melanin concentrating hormone (MCH) and its receptor 1. The development of MCHR1 antagonists are described with a specific perspective on different chemotypes investigated in efforts to overcome hERG liabilities while having orally active, potent and selective compounds with sufficient brain penetration. A chemometric comparison of ∼2000 diverse MCHR1 and ∼1000 diverse hERG ligands underline the structural similarities. A binding pocket analysis of a MCHR1 model and recent X-ray structures of GPCRs invoked in selectivity issues indicate a way to support future drug design.
TidsskriftBioorganic & Medicinal Chemistry Letters
Udgave nummer19
Sider (fra-til)6039-6047
Antal sider9
StatusUdgivet - 1 okt. 2012

ID: 47525846